Frank Holtey – Trademark Portfolio
Entity Type: 01
Frank Holtey holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 35 (Advertising & Business) — 1 filings in this category. The portfolio also extends into Class 1 (Chemicals) across 5 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include MYPLAS.
Am Zehnpfennigshof 14
50996 Köln
Showing of trademarks Trademarks
Trademark Classifications
Frank Holtey's trademark portfolio spans 5 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Advertising; business management; business administration; office functions
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Education; providing of training; entertainment; sporting and cultural activities
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Frequently Asked Questions
How many trademarks does Frank Holtey have?
Frank Holtey has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.
What trademark classes does Frank Holtey file in?
Frank Holtey files trademarks across 5 Nice Classification classes. The most active classes are Class 35 (Advertising & Business), Class 1 (Chemicals), Class 3 (Cosmetics & Cleaning), Class 41 (Education & Entertainment), Class 44 (Medical Services). Class 35 covers advertising; business management; business administration; office functions.
What are Frank Holtey's most well-known trademarks?
Frank Holtey's registered trademark portfolio includes well-known marks such as MYPLAS. These are among 1 currently registered trademark in the portfolio.
What is Frank Holtey's trademark registration success rate?
Frank Holtey has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.